Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers Panel Discussion

Session DOI (ID 524)

Lecture Time
08:00 - 08:00
Session Name
Immuno-oncology endpoints for approval: The case of tumor agnostic approval for MSI-H cancers
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
16.12.2018
Time
08:00 - 09:00